Injective (INJ) is on a bullish run, experiencing a 30% price increase in the past week. This surge is driven by significant buying interest and an upward movement in the Relative Strength Index (RSI). Market experts are optimistic, suggesting that if the bullish sentiment continues, Injective could see a further increase of 36.4%.
